Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePBHPrestige Consumer Healthcare$78.93-1.3%$84.17$64.94▼$90.04$3.95B0.43306,647 shs359,188 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePBHPrestige Consumer Healthcare0.00%-1.26%-6.02%-1.76%+17.07%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPBHPrestige Consumer Healthcare4.1737 of 5 stars2.34.00.03.52.81.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePBHPrestige Consumer Healthcare 2.50Moderate Buy$93.3318.25% UpsideCurrent Analyst Ratings BreakdownLatest BKL, A2M, ZO1, and PBH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025PBHPrestige Consumer HealthcareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPBHPrestige Consumer Healthcare$1.14B3.43$5.15 per share15.34$37.04 per share2.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePBHPrestige Consumer Healthcare$214.60M$4.2918.4016.582.4018.86%12.87%6.78%8/6/2025 (Estimated)Latest BKL, A2M, ZO1, and PBH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q4 2025PBHPrestige Consumer Healthcare$1.30$1.32+$0.02$1.00$289.36 million$296.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPBHPrestige Consumer Healthcare0.554.202.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipPBHPrestige Consumer Healthcare1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePBHPrestige Consumer Healthcare54049.42 million48.72 millionOptionableBKL, A2M, ZO1, and PBH HeadlinesRecent News About These CompaniesEULAV Asset Management Invests $1.67 Million in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 7 at 8:00 AM | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Raised to "Buy" at Wall Street ZenJuly 5 at 2:37 AM | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Leeward Investments LLC MAJuly 4 at 6:34 AM | marketbeat.comInvestors in Prestige Consumer Healthcare (NYSE:PBH) have seen impressive returns of 121% over the past five yearsJuly 3, 2025 | finance.yahoo.comWhy Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term - NasdaqJuly 2, 2025 | nasdaq.comWhy Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-TermJune 30, 2025 | zacks.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Allspring Global Investments Holdings LLCJune 28, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of "Moderate Buy" from AnalystsJune 27, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Position Increased by Bessemer Group Inc.June 26, 2025 | marketbeat.comAvior Wealth Management LLC Grows Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)June 22, 2025 | marketbeat.comAdvisor Resource Council Buys Shares of 27,337 Prestige Consumer Healthcare Inc. (NYSE:PBH)June 21, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for PBH EarningsJune 19, 2025 | marketbeat.comBoston Trust Walden Corp Sells 12,345 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)June 19, 2025 | marketbeat.comAssenagon Asset Management S.A. Reduces Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)June 19, 2025 | marketbeat.comZacks Research Issues Positive Estimate for PBH EarningsJune 18, 2025 | marketbeat.comMedtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial ContaminationJune 17, 2025 | globenewswire.com7,572 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by NorthCrest Asset Manangement LLCJune 15, 2025 | marketbeat.comShould You Continue to Hold Prestige Consumer Stock in Your Portfolio?June 11, 2025 | zacks.comWedge Capital Management L L P NC Trims Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)June 10, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and ...June 9, 2025 | gurufocus.comPrestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce ConferenceJune 9, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBKL, A2M, ZO1, and PBH Company DescriptionsPrestige Consumer Healthcare NYSE:PBH$78.93 -1.05 (-1.31%) Closing price 03:58 PM EasternExtended Trading$78.86 -0.07 (-0.08%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
